Sign up to access all valuation multiples
AnteoTech Ltd is a biotechnology company engaged in the development of specialty products and services and end-user diagnostic products focused on the Battery and Life Science diagnostics markets. Its key areas are the Energy and Life Science Division. The company is developing four products named AnteoX, Ultranode, AnteoBind NXT, and AnteoBind these products are used in the energy, diagnostic, and medical device markets. The company currently has a single segment which is the development of the AnteoTech IP.
1995
40
Last FY Revenue $0.3M
Last FY EBITDA -$7.5M
$41.8M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, AnteoTech achieved revenue of $0.3M and an EBITDA of -$7.5M.
AnteoTech expects next 12-month revenue of XXX and NTM EBITDA of XXX
See AnteoTech valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $0.3M | XXX | XXX | XXX |
| Gross Profit | XXX | $0.3M | XXX | XXX | XXX |
| Gross Margin | XXX | 100% | XXX | XXX | XXX |
| EBITDA | XXX | -$7.5M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -2547% | XXX | XXX | XXX |
| EBIT | XXX | -$8.2M | XXX | XXX | XXX |
| EBIT Margin | XXX | -2773% | XXX | XXX | XXX |
| Net Profit | XXX | -$5.7M | XXX | XXX | XXX |
| Net Margin | XXX | -1929% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of September 3, 2025, AnteoTech's stock price is AUD 0 (or $0).
AnteoTech has current market cap of AUD 65.5M (or $42.1M), and EV of AUD 65.1M (or $41.8M).
See AnteoTech trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $41.8M | $42.1M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of September 3, 2025, AnteoTech has market cap of $42.1M and EV of $41.8M.
AnteoTech's trades at 157.6x EV/Revenue multiple, and -5.4x EV/EBITDA.
Equity research analysts estimate AnteoTech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
AnteoTech's P/E ratio is not available.
See valuation multiples for AnteoTech and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $42.1M | XXX | $42.1M | XXX | XXX | XXX |
| EV (current) | $41.8M | XXX | $41.8M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 157.6x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -5.4x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -5.0x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -6.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -8.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAnteoTech's revenue per employee in the last FY averaged $7K, while opex per employee averaged $0.2M for the same period.
AnteoTech's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
AnteoTech's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for AnteoTech and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -2915% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $7K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 132% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 2873% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
AnteoTech acquired XXX companies to date.
Last acquisition by AnteoTech was XXXXXXXX, XXXXX XXXXX XXXXXX . AnteoTech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was AnteoTech founded? | AnteoTech was founded in 1995. |
| Where is AnteoTech headquartered? | AnteoTech is headquartered in Australia. |
| How many employees does AnteoTech have? | As of today, AnteoTech has 40 employees. |
| Is AnteoTech publicy listed? | Yes, AnteoTech is a public company listed on ASX. |
| What is the stock symbol of AnteoTech? | AnteoTech trades under ADO ticker. |
| When did AnteoTech go public? | AnteoTech went public in 2000. |
| Who are competitors of AnteoTech? | Similar companies to AnteoTech include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of AnteoTech? | AnteoTech's current market cap is $42.1M |
| Is AnteoTech profitable? | Yes, AnteoTech is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
